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RNY (YRNA)-derived small RNAs regulate cell death
and inflammation in monocytes/macrophages
Zoheir Hizir1,2, Silvia Bottini1,2, Valerie Grandjean1,2, Michele Trabucchi*,1,2,3 and Emanuela Repetto*,1,2,3
The recent discovery of new classes of small RNAs has opened unknown territories to explore new regulations of
physiopathological events. We have recently demonstrated that RNY (or Y RNA)-derived small RNAs (referred to as s-RNYs) are an
independent class of clinical biomarkers to detect coronary artery lesions and are associated with atherosclerosis burden. Here,
we have studied the role of s-RNYs in human and mouse monocytes/macrophages and have shown that in lipid-laden monocytes/
macrophages s-RNYexpression is timely correlated to the activation of both NF-κB and caspase 3-dependent cell death pathways.
Loss- or gain-of-function experiments demonstrated that s-RNYs activate caspase 3 and NF-κB signaling pathways ultimately
promoting cell death and inflammatory responses. As, in atherosclerosis, Ro60-associated s-RNYs generated by apoptotic
macrophages are released in the blood of patients, we have investigated the extracellular function of the s-RNY/Ro60 complex. Our
data demonstrated that s-RNY/Ro60 complex induces caspase 3-dependent cell death and NF-κB-dependent inflammation, when
added to the medium of cultured monocytes/macrophages. Finally, we have shown that s-RNY function is mediated by Toll-like
receptor 7 (TLR7). Indeed using chloroquine, which disrupts signaling of endosome-localized TLRs 3, 7, 8 and 9 or the more
specific TLR7/9 antagonist, the phosphorothioated oligonucleotide IRS954, we blocked the effect of either intracellular or
extracellular s-RNYs. These results position s-RNYs as relevant novel functional molecules that impacts on macrophage
physiopathology, indicating their potential role as mediators of inflammatory diseases, such as atherosclerosis.
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Macrophage apoptosis is a tightly regulated mechanism to
control tissue homeostasis, resolution of inflammation1,2 and
innate immune response against microbial infection.3 Induc-
tion of macrophage cell death can be initiated by a variety of
signals and stress factors, including bacterial toxins, DNA
damage, oxidant stress, endoplasmic reticulum stressors,
cytokines, activation of Fas death pathway, oxidized LDL
(oxLDL) and saturated fatty acids.3,4 Its physiopathological
importance is highlighted by the fact that apoptosis in
macrophages is involved in many inflammatory diseases,
such as atheroscleros is4 and Crohn's disease.5 In particular,
in the pathogenesis of atherosclerosis, both macrophage
apoptosis and the inflammatory response have major roles
from early to advanced phases of lesion formation.6 In early
phases, macrophages engulf lipoproteins and lipids, and
become the so-called foam cells, which secrete inflammatory
cytokines and undergo apoptosis. Rapid efferocytic
clearance of the apoptotic foam cells leads to suppression of
the inflammatory response ultimately retarding lesion
progression.7 However, in advanced lesions, macrophage
apoptosis is not properly coupled with phagocytic clearance
leading to the upregulation of inflammation and to necrotic
plaque formation.8 This may ultimately lead to clinical events,
such as heart attack or stroke.6
In addition to microRNAs, piwi-interacting RNAs (piRNAs)
and siRNAs, recent analyses from high-throughput sequen-
cing of cell cultures and tissues have revealed the existence of
many other classes of small RNAs, including those from sno-
RNAs and tRNAs9 or from Alu repeat elements,10 indicating
that cells may generate a wide range of regulatory small RNAs
with a broad variety of processing mechanisms and functions.
Using small RNA high-throughput sequencing, we recently
demonstrated that the ~110 nucleotides (nt) long Ro-
associated Y RNAs (also called RNYs or YRNAs), are
processed into small sequences in apoptotic and lipid-laden
macrophages.1,11 We found that the RNY-derived small RNAs
vary in length from ~24 to ~ 34 nt and map at the end of the
stem regions of the RNYs. We have referred to these small
RNAs as s-RNYs. RNY genes account for four copies in
human (RNY1, 3, 4 and 5) and two in mouse genome (RNY1
and 3), and their sequence is well conserved among
vertebrates.12 The expression of s-RNYs is significantly
upregulated in mouse models for atherosclerosis (namely
the ApoE−/− and Ldlr−/−mice) and in the serum of 263 patients
with coronary artery disease (CAD) compared with 514 age-
matched controls.1,11 Biostatistical analysis positioned
s-RNYs as relevant novel independent diagnostic biomarkers
for CAD and associated it with atherosclerosis burden.1,11
In this report, we investigated the role of s-RNYs in human
and mouse monocytes/macrophages. By either inducing or
inhibiting the expression, we have shown that s-RNYs activate
both caspase-dependent cell death and NF-κB-dependent
inflammation in cultured monocytes/macrophages. This phe-
notype was rescued by treating the monocytes/macrophages
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with chloroquine and IRS954 (specific inhibitor of Toll-like
receptor 7 (TLR7)), indicating that s-RNYs activate TLR7.
Finally, the isolated s-RNY/Ro60 complex by affinity purifica-
tion also promoted TLR7-dependent apoptosis and inflamma-
tion when added in the medium of cultured monocytes/
macrophages. This effect was rescued by s-RNY antisense
oligonucleotides and by TLR7 inhibitors. Overall, these data
indicate that s-RNYs are intrinsic components of the machin-
ery regulating lipid-ladenmacrophage phenotype and function
as mediators of inflammation/apoptosis. In atherosclerosis,
we speculate that s-RNYs promote the progression of the
disease. Endothelial cells, which do not express TLR7 or
s-RNYs when stimulated with pro-atherogenic agents,1 are
not activated by s-RNYs, confining the extracellular role of
s-RNYs to immune cells.
Results
Pro-atherogenic stimuli induce the expression of RNY-
derived small RNAs in monocytes/macrophages. To
explore the potential involvement of s-RNYs in regulating
macrophage foam cells, we first analyzed the expression
pattern of s-RNYs in oxLDL-treated or palmitic acid (PA)-treated
macrophages in a time course experiment. Either oxLDL or PA
treatment promotes both apoptosis and inflammatory response
by regulating signaling pathways downstream TLRs activation,
leading to the upregulation of NF-κB-dependent inflammation
and caspase-dependent cell death.13–16
In accordance with previous reports,16,17 we found apopto-
sis and inflammation activation in monocytes/macrophages
treated with pro-atherogenic stimuli, such as PA or oxLDL in
combination with thapsigargin (Tg) (Figure 1). In particular, our
data revealed that either oxLDL or PA treatment of human
monocytes or mouse macrophages activated caspase-
dependent apoptosis, which depends on the cleavage of
caspase 3, after 48 and 9 h, respectively (Figure 1). NF-κB,
which depends on IκBα degradation, was also activated after
48 and 9 h, respectively. Importantly, as shown in Figure 1,
s-RNYexpression was also induced after 48 and 9 h of oxLDL
or PA treatment, respectively. Small RNA derived from the
RNY5 was not measured by stem-loop RT-qPCR because
only the 3’ fragment is generated from this RNA in lipid-laden
macrophages.1 These data indicate a timing correlation
between s-RNY induction and cell signaling activation,
inferring a possible role of s-RNYs in regulating both NF-κB-
dependent inflammation and caspase-dependent cell death.
s-RNYs regulate apoptosis and inflammatory response
in lipid-laden monocytes/macrophages. We evaluated the
effects of s-RNYs on macrophage apoptosis using flow
cytometry. As siRNA against the terminal loop of RNY
generates s-RNYs (Supplementary Figures S1a and c)
associated with Ro60 (ref.18) mimicking the induction of the
processing that occurs in lipid-laden macrophages and
apoptotic monocytes/macrophages, we used this strategy to
induce s-RNY expression. We found that inducing s-RNY
expression caused an upregulation of the apoptosis
mediated by PA treatment of monocytes/macrophages (left
panels of Figures 2a and b). We rescued the apoptosis
upregulation by co-transfecting the 2'-OMe-RNA antisense
oligonucleotides to s-RNYs (AS s-RNYs) (Supplementary
Figure S1b), indicating that this effect was specific of s-RNYs.
Similarly, we found a downregulation of the apoptosis when
we knocked down endogenous s-RNY expression in mono-
cytes/macrophages treated with oxLDL/Tg (middle panels of
Figures 2a and b). Notably, by promoting s-RNY maturation
we induced the apoptosis in untreated monocytes/macro-
phages, which was also rescued by co-transfecting the
2'-OMe-RNA antisense oligonucleotides to s-RNYs (right
panels of Figures 2a and b). These results indicate that
atherogenic stimuli-induced s-RNYs are an intrinsic compo-
nent of the machinery regulating apoptosis in lipid-laden
monocytes/macrophages.
This conclusion was confirmed by western blot. Indeed, as
shown in Figures 2c and d, caspase 3 was activated by inducing
s-RNY expression, while we observed a significant reduction
upon s-RNY knockdown in PA- or oxLDL-treated monocytes/
macrophages, or in s-RNY-induced apoptosis. These data
indicate that s-RNYs promote caspase-dependent apoptosis in
monocytes/macrophages. Moreover, s-RNYs were also able to
activate NF-κB pathway in either PA- or oxLDL-treated or
unstimulated monocytes/macrophages, as we demonstrated
by checking the expression levels of IκBα (Figures 2c and d).
Moreover, we tested the effect of inducing s-RNY maturation on
the expression regulation of death cytokines and nitric oxide
activated by NF-κB pathway in bone marrow-derived macro-
phages (BMDMs) treated with the general macrophage activator
lipopolysaccharide (LPS). As shown in Supplementary
Figure S2, s-RNYs enhanced a significant upregulation of the
mRNAs encoding for NOS2A, interleukin (IL)-6, IL-12b and
IL-1b. Therefore these data indicate that s-RNYs activate
caspase-dependent cell death and NF-κB-dependent inflamma-
tion in lipid-laden monocytes/macrophages.
Extracellular s-RNY/Ro60 complex promotes apoptosis
and inflammation in monocytes/macrophages. There is
evidence that s-RNYs are associated with Ro60, and that this
association is most likely responsible for the stability of
s-RNYs.1,19 Given that s-RNYs have been found upregulated
in the serum of patients with CAD compared with control,1 we
investigated whether the extracellular s-RNY/Ro60 complex
also contributes to the apoptotic and inflammatory phenotype
of lipid-laden macrophages. Briefly, we immunopurified the
Ro60 complex from staurosporine (STS)-treated Hek-293T
cells and control, reasoning that Ro60 is mainly associated
with RNY in control cells, while it is mainly associated with
s-RNYs in STS-treated cells (Supplementary Figure S3a
and b). Either RNY/Ro60 or s-RNY/Ro60 complexes were
added into the medium of cultured monocytes at different
concentration and time. As shown in Figure 3a, only s-RNY/
Ro60 complex at the minimal dose of 10 μg/ml induced cell
death after at least 12 h of incubation. Importantly, to
determine a specific pro-apoptotic effect of the s-RNYs, we
incubated the s-RNY/Ro60 complex with the 2'-OMe-RNA
antisense oligonucleotides to s-RNYs. As shown in
Figures 3b and c, in human monocytes or mouse primary
macrophages the s-RNY/Ro60 complex-induced apoptosis
was blocked by using s-RNY antisense oligonucleotides. As
we have shown for the intracellular, also the extracellular
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Figure 1 Atherogenic stimuli induce s-RNYexpression in monocytes/macrophages, which is timely correlated with inflammatory and cell death responses. Quantitative RT-
PCR detecting the indicated s-RNYs at the indicated time in either human THP1 monocytes or BMDMs stimulated with either 100 μg/ml of oxLDL in combination with 0.25 μM of
Tg (upper panels of a and b, respectively) or with 0.25 mM of PA in complex with BSA (upper panels of c and d, respectively). The data were normalized by U2 snRNA and
presented as mean and S.D. (n= 4). Each condition was subjected to immunoblot with the indicated antibodies (lower panels) to analyze the time correlation between the s-RNY
induction and the inflammatory or cell death responses. One-way ANOVA with post-hoc Tukey test: *Po0.05; **Po0.01; ***Po0.001
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Figure 2 s-RNYs promote apoptosis and inflammation in lipid-laden macrophages. Cell death data by flow cytometry from human THP1 cells (a) or mouse BMDMs (b)
transfected with a cocktail of siRNAs against the terminal loop of all RNYs (siRNYs) to induce s-RNY maturation, a cocktail of 2'-OMe-RNA antisense oligonucleotides (AS) to all
s-RNYs expressed, or control. Cells were stimulated with 0.25 mM of PA for 18 h (left panel), 0.25 μM Tg in combination with 100 μg/ml of oxLDL for 48 h (middle panel) or left
unstimulated (right panel). Percentage of apoptotic cells was determined by staining with annexin V-FITC. Data are presented as mean and S.D. (n= 3). Immunoblot analysis of
IκBα, actin, total caspase 3 (casp3) and its cleaved form (c-casp3) in THP1 cells (c) or BMDMs (d) transfected with either a cocktail of AS to all s-RNYs or control. Cells were
stimulated with 0.25 mM of PA for 18 h (left panel), 0.25 μM Tg in combination with 100 μg/ml of oxLDL for 48 h (middle panel) or left unstimulated (right panel). Student’s t-test:
*Po0.05; **Po0.01; ***Po0.001
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s-RNYs promote caspase 3 and NF-κB activation by inducing
cleaved caspase 3 and inhibiting IκBα expression levels
(Figure 3c). However, naked synthetized s-RNYs added in
the medium was not able to activate monocytes/macro-
phages (Supplementary Figure S4a), while they enhanced
apoptosis and inflammation when transfected (Supple-
mentary Figure S4b). These data may indicate that s-RNYs
need to be complexed with Ro60 to get internalized by the
cells and activate them. Moreover, RNY/Ro60 complex does
not have any effect (Figure 3a), indicating that the pro-
apoptotic and pro-inflammatory effect is only specific to the
s-RNYs. Overall, these data indicate that extracellular
s-RNYs but not the long form RNY induce caspase-
dependent cell death and NF-κB-dependent inflammation in
monocytes/macrophages.
s-RNYs activate TLR7 to induce apoptosis and inflam-
mation in monocytes/macrophages. As anti-Ro60 single-
stranded RNA-containing immunocomplex stimulates inflam-
mation through TLR7/8,20,21 we have investigated whether
the s-RNY-induced apoptosis and inflammation in mono-
cytes/macrophages is also mediated by the activation of
intracellular TLRs. We therefore evaluated whether the
chloroquine, a molecular agent that disrupts signaling of
endosome-localized TLRs 3, 7, 8 and 9 or the more specific
TLR7/9 antagonist, the phosphorothioated oligonucleotide
IRS954,22 were able to inhibit the pro-apoptotic and pro-
inflammatory effects of s-RNYs. As TLR9 is supposed to
recognize only DNA, in our case the use of oligonucleotide
IRS954 was meant to check whether s-RNYs specifically
activate TLR7, which recognizes single-stranded RNA.
Importantly, as shown in Figures 4a and b, flow cytometry
and western blot analyses indicate that intracellular s-RNY-
dependent activation of monocytes/macrophages was inhib-
ited by chloroquine or IRS954. In particular, chloroquine or
IRS954 blocked the s-RNY induction of caspase 3-
dependent apoptosis and the IκBα downregulation-depen-
dent inflammation. Similar results were obtained for the
extracellular s-RNYs (Figures 5a and b). Overall, these data


























































Figure 3 Extracellular s-RNYs promote apoptosis and inflammation in lipid-laden macrophages. (a) Time and dose response of cell death by flow cytometry from human
THP1 cells incubated with the immunopurified complex of s-RNY/Ro60 or RNY/Ro60. Incubation with BSA was used as control. Data are presented as mean and S.D. (n= 5).
One-way ANOVAwith post-hoc Tukey test: *Po0.05. (b) Flow cytometry from human THP1 cells (left panel) or mouse BMDMs (right panel) incubated with 10 μg/ml of either the
immunopurified complex of s-RNY/Ro60 or BSA, as control. s-RNY/Ro60 complex was previously incubated for 16 h in rotation at 4 °C with either 40 nM of 2'-OMe-RNA AS to
s-RNYs or control. Data are presented as mean and S.D. (n= 5). Student’s t-test: *Po0.05. (c) Immunoblot analysis of IκBα, actin, total caspase 3 (casp3) and its cleaved form
(c-casp3) in THP1 cells (left panel) or BMDMs (right panel) incubated s-RNY/Ro60 complex previously pretreated with either AS to s-RNYs or control
s-RNYs induce death and inﬂammation in macrophage
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of action and mediates the s-RNY-dependent apoptotic and
inflammatory response in monocytes/macrophages.
Taken together, our data suggest that s-RNY is an intrinsic
component of the machinery regulating lipid-laden macro-
phage phenotype and function as mediator of inflammation/
apoptosis. Endothelial cells, which do not express TLR7 or
s-RNYs when stimulated with oxLDL/Tg,1 are not activated by
extracellular s-RNYs (Supplementary Figure S5), confining to
immune cells the extracellular role of s-RNYs during athero-
sclerosis pathogenesis.
Discussion
Recently, we have uncovered for the first time a previously
unsuspected aspect of macrophage activation whereby athero-
genic lipids and lipoproteins induce the processing of the RNA-
Polymerase III-driven non-coding RNYs into small RNAs, the s-
RNYs.1 RNYs are characterized by extensive base pairing of the
5’ and 3’ regions and by the association with the proteins Ro60
and La/SSB, which are often targeted by the immune system in
several autoimmune diseases.23 Although, the role of RNYs
per se is still poorly understood, s-RNYs have been previously
described in T cells stimulated with anti-FAS antibody,23 in germ
cells, and in acute lymphoblastic leukemia.24,25 In addition, we
found that the expression of s-RNYs is significantly upregulated
in aortic arches and blood of two mouse models for athero-
sclerosis, the ApoE−/− and Ldlr−/− mouse lines. Moreover, we
alsomeasured the s-RNYexpression in 263 sera of patients with
CAD and 514 sera from age-matched control individuals.1
Biostatistical analysis positioned s-RNYs as relevant novel
independent diagnostic biomarkers for CAD.1 The findings we
are presenting here reveal for the first time that both intracellular
or extracellular s-RNYs increase inflammation and cell death in
lipid-laden macrophages by activating TLR7. RNY, from which
s-RNY derived, is not able to activate macrophages, suggesting
that only s-RNY can be recognized by TLR7. In concordance to
thismechanism, upon s-RNY inductionweobserveda significant
upregulation of cleaved caspase 3 and downregulation of IκBα,
which activate apoptosis and inflammation, respectively. In fact,
IκBprotein family (mainly IκBα) inhibits theDNAbinding activity of
NF-κB transcription factors, which have an important role in
inflammation and in cell survival/apoptosis balance in
macrophages.26 Noteworthy, we found this novel function of
s-RNYs is conserved in human and mouse monocytes/macro-
phages. Interestingly, also the sequence of s-RNYs and the
structure of the precursor RNYs are well conserved between
human and mouse.12 Thus, a conserved pathway of s-RNY








































































Figure 4 Intracellular s-RNYs activate TLR7 to promote apoptosis and inflammation in monocytes/macrophages. Cell death data by flow cytometry from human THP1 cells
(a – left panels) or mouse BMDMs (b – left panels) transfected with a cocktail of siRNAs against the terminal loop of all RNYs (siRNYs) to induce s-RNY maturation or control
(siCTL). Cells were incubated with 50 mM of chloroquine for 48 h (left panels) or with the TLR7/9 specific inhibitor IRS954 at 10 μg/ml of concentration for 48 h (middle panels).
Percentage of apoptotic cells was determined by staining with annexin V-FITC. Data are presented as mean and S.D. (n= 3). The same experimental conditions were analyzed by
immunoblot of IκBα, actin, total caspase 3 (casp3) and its cleaved form (c-casp3) in THP1 cells (a – right panel) or BMDMs (b – right panels). Student’s t-test: *Po0.05;
***Po0.001
s-RNYs induce death and inﬂammation in macrophage
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evolutionary pressure to maintain such a mechanism in
mammals.
The presence of small RNAs in the extracellular environ-
ment ignited the hypothesis that cells selectively release small
RNAs to mediate cell–cell signaling via paracrine or endocrine
routes.27 In particular, extracellular miRNAs have been found
to associate to Ago proteins and form stable ribonucleoprotein
complexes or entrapped to extracellular vesicles, such as
apoptotic bodies and exosomes. Only miRNAs circulating in
extracellular vesicles can be transferred to recipient cells and
alter gene expression programmes.27 Along with others, we
have found that circulating levels of s-RNYs are dysregulated
in cardiovascular disorder 1,28 and in aging.29 Here, we have
demonstrated that as miRNAs, also extracellular Ro60-
associated s-RNYs stimulate cell death and inflammation of
recipient immune cells. Importantly, extracellular synthetic
s-RNYs cannot activatemonocytes/macrophages, suggesting
that the association between s-RNY and Ro60 would permit
the internalization of s-RNY into the cells.
There is evidence that most regulatory small RNA families
target multiple genes that have related functions, and thereby
exert strong physiopathological effects.30 s-RNYs are good
examples in lipid-laden macrophages, because they activate
caspase 3 and NF-κB pathways driving cell death and
inflammation and, doing so, effectively reinforcing pro-
atherogenic networks. Therefore, in addition to miRNAs, such
as miR-155,31 s-RNYs represent a major group of small RNAs
that regulate immune response in the pathogenesis of
atherosclerosis. In accordance with this conclusion, our
previous study unraveled a significant increase of s-RNY
expression during atherosclerosis development and in the
serum of patients with stable CAD, indicating that s-RNY can
be potentially used as therapeutic targets for atherosclerosis.
In conclusion, our results uncover a strategy by which
atherogenic lipids and lipoproteins induce the biogenesis of
s-RNYs in macrophages to enhance inflammation and cell
death by activating TLR7 (Figure 6). We speculate that
s-RNYs promote the progression of the disease, as extra-
cellular s-RNYs activate the apoptotic and inflammatory
response to unstimulated monocytes/macrophages. Alto-
gether, this study contributes to the diversity of the regulatory
small RNA profile that impacts on the physiopathology of lipid-
laden macrophages and atherosclerosis development. As
















































Figure 5 Extracellular s-RNYs activate TLR7 to promote apoptosis and inflammation in monocytes/macrophages. Cell death data by flow cytometry from human THP1 cells
(a – left panel) or mouse BMDMs (a – right panel) incubated with 10 μg/ml of the immunopurified complex of s-RNY/Ro60, RNY/Ro60 or BSA. Cells were incubated with 50 mM of
chloroquine for 24 h or with IRS954 at 10 μg/ml of concentration for 24 h, as indicated. Percentage of apoptotic cells was determined by staining with annexin V-FITC. Data are
presented as mean and S.D. (n= 6 for BMDMs and 4 for THP1 cells). The same experimental conditions were analyzed by immunoblot of IκBα, actin, total caspase 3 (casp3) and
its cleaved form (c-casp3) in THP1 cells (b – left panel) or BMDMs (b – right panel). Student’s t-test: *Po0.05; **Po0.01
s-RNYs induce death and inﬂammation in macrophage
Z Hizir et al
6
Cell Death and Disease
regulated mechanisms and their physiopathological impor-
tance is highlighted by the fact that its dysregulation is involved
in many human diseases, such as atherosclerosis,7 Crohn's
disease5 and microbial infections,3 it is tempting to speculate
that s-RNYs may have a key role in regulating diverse aspects
of development, homeostasis and diseases.
Materials and Methods
Reagents. LPS, Tg, STS, bovine serum albumin (BSA) and PA were purchased
from Sigma (Saint-Quentin Fallavier, France). oxLDL was purchased from
Clinisciences (Nanterre, France). siRNA control was from Dharmacon (GEHealth-
Care Europe, Villebon Sur Yvette, France), whereas control 2'-OMe-RNA antisense
oligonucleotide was from Qiagen France Sas (Courtaboeuf Cedex, France). PA was
solubilized in sterile water at 70 °C for 30 min, then 1% of 1 N NaOH was added
each 5 min for 10 min, vortexing each time. Afterward, the solubilized PA was mixed
with 1% of fatty acid-free BSA in Dulbecco’s modified Eagle's medium (DMEM) at
the final 2 mM. For PA treatment of cells, we used as control 1% of fatty acid-free
BSA-treated cells in FBS-free DMEM.
Primary macrophages. Bone marrow cells were collected from femurs and
tibias of 10-week-old male C57BL/6 J mice by flushing with sterile medium as
previously described.32 To differentiate into macrophages, bone marrow cells (106)
were plated in 10-cm plates in 7 ml of BMDM medium (DMEM supplemented with
20% low-endotoxin fetal bovine serum, 30% L929-cell conditioned medium, 1%
L-glutamine, 1% Pen/Strep, 0.5% Na pyruvate and 0.1% β-mercaptoethanol), and
fed with 2.5 ml of fresh medium every 2 days for 7 days.
Cell transfection and immunoblotting. BMDMs and the monocyte cell
line THP1 (ATCC/LGC standards, Molsheim Cedex, France) were transiently
transfected for 48 h with Lipofectamine 2000 (Invitrogen/Life Technologies, Villebon
Sur Yvette, France) according to the manufacturer’s instructions. Either siRNAs or
chemically synthetized s-RNYs (Eurogentec SA, Angers, France) were transfected
at the final concentration of 24 nM, whereas 2'-OMe-RNA antisense oligonucleo-
tides to s-RNYs (Eurogentec) were transfected at the final concentration of 100 nM.
Sequence of siRNAs and antisense oligonucleotides are indicated below.
Immunopurification of s-RNY/Ro60 complex. In all, 10-cm dishes of
unstimulated or STS-stimulated Hek-293T cells were irradiated once at 400mJ/cm2
with 254nm UVC light. Afterward, cells were lysate and incubated 16 h at 4 °C with
rotation with anti-Ro60 antibody (sc-100844 – Santa Cruz Biotechnology Inc.,
Heidelberg, Germany). The anti-Ro60 antibody was previously covalently bound to
protein G/magnetic beads by 25 mM of dimethypimelimidate dihydrochloride
(Sigma, D-8388) dissolved in 0.2 M triethanolamine according to the manufacturer’s
instruction. Immunoprecipitation was washed four times and the s-RNY(RNY)/Ro60
complex was eluted with 30μl of 0.1 M glycin-HCl (pH 2.5) and then neutralized with
3μl of 1 M Tris at pH 7.5. When indicated, the s-RNY/Ro60 complex was incubated
for 16 h in rotation at 4 °C with either 40 nM of 2'-OMe-RNA antisense
oligonucleotides against the s-RNYs (human or mouse) or control.
Apoptosis assay. Apoptosis was assayed using flow cytometry in BMDMs or
THP1 cells by staining with FITC-conjugated annexin V and Dapi as previously
described.33 The number of annexin V-positive cells was counted and expressed as
a percent of the total number of cells.
Northern blot. Northern blot from RNA immunoprecipitation was performed as
previously described.34 RNA was isolated from cells using Trizol (Invitrogen), resolved
on 10% polyacrylamide-urea gels and electroblotted onto HyBond N+ membranes.
Membranes were hybridized overnight with radiolabeled DNA antisense oligonucleotides
to s-RNYs in ExpressHyb solution (Clontech/Ozyme Saint-Quentin En Yvelines,
France). After hybridization, membranes were washed three times with 2X SSC and
0.05% SDS, two times with 0.1X SSC and 0.1% SDS, exposed overnight onto a film.
Northern blot probe is detailed in Supplementary Table S1.
mRNA and s-RNY expression analysis. RNA expression by quantitative
RT-PCR was carried out by using standard procedures. Briefly, for mRNA, total RNA
was isolated from cells using Trizol and cDNA was synthesized with a random
hexonucleotides using Superscript III (Invitrogen). For s-RNYs detection by
quantitative RT-PCR, we used a stem-loop quantitative RT-PCR method according
Repetto et al.1 This method allows the detection of the s-RNYs derived from only the
5’ end of the precursor by quantitative RT-PCR analysis, namely the s-RNY1-5p and
s-RNY3-5p from mouse and s-RNY1-5p, s-RNY3-5p, and s-RNY4-5p from human.
Quantitative RT-PCRs using Sybr Green (Invitrogen) were performed on a StepONE
system (Applied Biosystem/Life Technologies SAS, Villebon Sur Yvette, France).
Expression was considered undetectable with Ct value ≥ 40. Target small RNA
expression value was normalized with two reference endogenous genes: U2 or U6
snRNAs. The relative expression level was then further normalized by the 2−ΔΔCt
method. Student's t-test was performed to assess statistical significance. The primer
sequences are detailed in Supplementary Table S1.
Antibodies for western blot. Goat anti-actin (I-19) and IκBα (H-4) and
mouse anti-Ro60 (AA3) antibodies were purchased from SantaCruz. Rabbit anti-
cleaved caspase 3 (Asp175) and rabbit anti-caspase 3 (8G10) antibodies were




































Figure 6 A model for s-RNY mode of action in lipid-laden monocytes/macrophages that exerts signaling pathway effects enhancing cell death and inflammation
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siRNAs and modified-RNA oligonucleotides. Custom siRNAs or
modified-RNA oligonucleotides were synthesized by Eurogentec. Regular
oligonucleotides were synthesized by Sigma.
 Mouse/human siRNA against RNY1 terminal loop 5′-CAGUCAGUUACAGAUUGAA-3′.
 Mouse/human siRNA against RNY3 terminal loop 5′-CAACCAGUUACAG
AUUUCU-3′.
 Mouse/human 2'-OMe-RNA antisense to s-RNY1-5p 5′-UUGAGAUAACUCA
CUACCUUCGGACCAGCC-3′.
 Mouse/human 2'-OMe-RNA antisense to s-RNY1-3p 5′-AAGACUAGUCAAG
UGCAGUAGUGAGAAG-3′.
 Mouse 2'-OMe-RNA antisense to s-RNY3-5p 5′-UAAACACCACUACUCUC
GGACCAACC-3′.
 Human 2'-OMe-RNA antisense to s-RNY3-5p 5′-UAAACACCACUGCAC
UCGGACCA-3′.
 Human 2'-OMe-RNA antisense to s-RNY3-3p 5′-AAGGCUAGUCAAGUG
AAGCAGUGGGAG-3′.
 Mouse 2'-OMe-RNA antisense to s-RNY3-3p 5′-AAGGCUGGUCAAGUGA
AGCAGUGGGAGC-3′.
 Human siRNA against RNY4 terminal loop 5′-GUGUCACUAAAGUUGGUAU-3′.
 Human siRNA against RNY5 terminal loop 5′-AGUUGAUUUAACAUUGUCU-3′.
 Human 2'-OMe-RNA antisense to s-RNY4-5p 5′-UUCUGAUAACCCACUACCA
UCGGACCAGCC-3′.
 Human 2'-OMe-RNA antisense to s-RNY4-3p 5′-AAGCCAGUCAAAUUUAGCA
GUGGGGGG-3′.
 Mouse 2'-OMe-RNA antisense to s-RNY5-3p 5′-CAAGCGCGGUUGUGGGGGGA-3′.
 IRS954 5′-TGCTCCTGGAGGGGTTGT-3′.
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